Nav: Home

Research team first to identify AF1q protein associated with multiple myeloma, EMD

June 10, 2016

LOUISVILLE, Ky. - A group of researchers from the University of Louisville, Japan and Austria is the first to identify a protein, AF1q, associated with multiple myeloma and a condition that occurs in approximately one-fourth of very aggressive multiple myeloma, extramedullary disease or EMD.

The group will present their findings at the European Hematology Association's 21st Congress, June 10-12, in Copenhagen, Denmark. Their presentation is entitled "High expression of AF1q is an adverse prognostic factor and a prediction marker of extramedullary disease in multiple myeloma."

William Tse, M.D., the Marion F. Beard Endowed Chair in Hematology and chief of the Division of Blood and Bone Marrow Transplantation at UofL, was senior investigator on the project, working with researchers in Tokyo and Vienna.

Multiple myeloma is one of four types of myeloma and the most prevalent. It is a form of blood cancer that develops in the bone marrow. In multiple myeloma, normal plasma cells transform into malignant myeloma cells and produce large quantities of toxic abnormal immunoglobulin called monoclonal protein that can damage multiple organs. The monoclonal protein produced by the myeloma cells interferes with normal blood cell production.

The American Cancer Society estimates that 30,330 new cases of multiple myeloma will occur in the United States in 2016 and about 12,600 people will die from it.

Approximately 25 percent of patients with multiple myeloma also simultaneously develop extramedullary disease. This disease occurs when the myeloma cells form tumors outside of the bone marrow in the soft tissues or organs of the body. The prognosis of myeloma patients with EMD behaves like other metastatic cancers and is extremely poor because its clinical course is very aggressive, Tse said.

"We know that multiple myeloma with EMD involvement has an extremely poor outcome," Tse said. "However, not much is known about the mechanism in which EMD progresses."

The group looked at an oncogene, AF1q discovered in Tse's lab, which is expressed in hematological cancer cells and is known to be related to multiple myeloma. Its presence indicates a poor prognosis for the patient.

Tse and the team analyzed the degree of expression of AF1q in 117 patients with multiple myeloma. They found that EMD was present in 25 percent of patients with a low AF1q expression and in 44.7 percent of patients with a high AF1q expression.

"We found that the incidence of EMD was significantly higher in patients with high expression of AF1q than those with low expression," Tse said. "The significance of this finding gives us a tentative approach to target this marker and could lead to new therapies for this subtype of myeloma."

Tse's research team included Drs. Shotaro Hagiwara, the lead author and chief of hematology, and Sohtaro Mine of the National Center for Global Health and Medicine in Tokyo, Ana-Iris Schiefer of the Medical University of Vienna and Lukas Kenner of the Ludwig Boltzmann Institute for Cancer Research and Medical University of Vienna. The study patient cohort was organized by Hagiwara.

Tse practices with University of Louisville Physicians-Medical Oncology/Hematology and with UofL's James Graham Brown Cancer Center, a part of KentuckyOne Health.
-end-


University of Louisville

Related Bone Marrow Articles:

Researchers reveal developmental mechanisms behind rare bone marrow disorder
Myelodysplastic syndrome is an umbrella term used to describe disorders characterized by the bone marrow's inability to produce normal blood cells.
Researchers propose noninvasive method to detect bone marrow cancer
For the first time, researchers have shown that using magnetic resonance imaging can effectively identify bone marrow cancer (myelofibrosis) in an experimental model.
Bone marrow inflammation predicts leukemia risk
Cancer is generally thought to arise from genetic damage within individual cells, but recent evidence has suggested that abnormal signaling in the surrounding tissue also plays an important role.
New approach could make bone marrow transplants safer
Bone marrow transplantation is the only curative therapy for the millions of people living with blood disorders like sickle cell anemia, thalassemia, and AIDS.
Bone marrow lesions can help predict rapidly progressing joint disease
A new study from the Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, shows lesions, which can best be seen on MRI scans, could help identify individuals who are more likely to suffer from more rapidly progressing osteoarthritis.
Fat cells originating from bone marrow found in humans
Researchers at the University of Colorado Anschutz Medical Campus have found that fat cells produced by stem cells from the bone marrow may be linked to chronic illnesses like diabetes, cardiovascular disease, kidney disease and some cancers.
Zebrafish reveal drugs that may improve bone marrow transplant
Using large-scale zebrafish drug-screening models, researchers at Boston Children's Hospital have identified a potent group of chemicals that helps bone marrow transplants engraft or 'take.'
The secrets of bone marrow: What leads to healthy blood cell production?
The Medical College of Wisconsin has received a five-year, $635,000 grant from the National Institutes of Health's National Heart, Lung and Blood Institute to identify new potential treatments for diseases that inhibit the growth of blood cells and diseases in which the blood cells develop abnormally.
Clinical trial uses patients' own cells for treatment after bone marrow transplant
A clinical trial using personalized cellular therapy has begun enrolling children and adults suffering from graft-versus-host-disease, a life-threatening complication of bone marrow transplantation in which donor immune lymphocytes attack the organs of the bone marrow transplant recipient.
3-D engineered bone marrow makes functioning platelets
An international research team has reported development of the first three-dimensional tissue system that reproduces the complex structure and physiology of human bone marrow and successfully generates functional human platelets.

Related Bone Marrow Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...